Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

High Risk, High Reward: Jon Najarian’s Top 3 ETF Plays for 2013: Direxion Daily Real Estate Bull 3X (ETF) (DRN) and More

Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), and Merck & Co., Inc. (NYSE:MRK) are the three largest holdings in the XLV, collectively representing more than 30% of the investment portfolio. On a fundamental basis, health care has historically been considered a defensive sector. The sector also has strong growth prospects and would likely be less affected in the event of a broader market pullback. Valuations are supported by solid dividend yields.

Bank of America’s chief technical analyst, Mary Ann Bartels, believes healthcare is entering a “new bull market” on a long-term technical basis. The sector is breaking out to new all-time highs and she concurs that valuations are still attractive.

Considerations for ETF Trading / Investing

When considering an alternative investment vehicle such as an ETF / ETN, investors need to pay attention to the average daily volume before making a purchase decision. A good rule-of-thumb for retail investors is to ensure that their prospective fund has at least 100,000 shares traded on a daily basis. Otherwise, the bid/ask spread on the market becomes too wide. Liquidity is always important but becomes less critical the longer your duration.

Out of the three recommendations, DRN has the highest risk for numerous reasons. In addition to the triple leverage, investors need to be concerned about time decay. Direxion is able to offer the 3x performance of the underlying index due to the derivatives involved, and this causes the share price to erode over time. DRN also has the lowest average daily volume among the group.

Foolish Bottom Line

In conclusion, I believe AMJ and XLV are clear winners for long-term investment. Energy MLPs and health care are two important areas for portfolio diversification. In contrast, I would exercise caution with DRN, given the risks involved and significant performance we’ve already seen in real estate.

Thanks for reading, and consider subscribing to my posts for more Fool ideas on outperforming the market. Requests for future articles may be submitted to fool@johnmacris.com.

The article High Risk, High Reward: Jon Najarian’s Top 3 ETF Plays for 2013 originally appeared on Fool.com and is written by John Macris.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.